期刊文献+

糖肽类抗生素的研究进展 被引量:2

Research advances in glycopeptide antibiotics
下载PDF
导出
摘要 糖肽类抗生素不仅有较高的选择性抗HIV、FIPV和SARS活性,还有显著的抗革兰氏阳性菌活性,但致病菌耐药性的不断产生给临床治疗带来极大困难。本文从抗菌机制、耐药机制和结构修饰等方面对糖肽类抗生素进行介绍和综述,并对糖肽类抗生素的发展前景进行预测和展望。 Glycopeptide antibiotics not only possess selective activities against HIV, FIPV and SARS, but also have potent activities against Gram-positive bacteria. Meanwhile, the occurrence of bacterial resistance bring about significant challenges in clinical therapy. Recent progresses of glycopeptide antibiotics, including antimicrobial mechanism, mechanism of resistance, structural modification, etc, were summarized in this paper. Further perspective on many aspect concerning glycopeptides is also provided.
机构地区 山东大学药学院
出处 《中国药科大学学报》 CAS CSCD 北大核心 2008年第2期188-192,共5页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.20372043) 山东省科技攻关项目(No.2005GG3202098)~~
关键词 糖肽类抗生素 抗菌机制 耐药机制 结构修饰 HIV FIPV SARS glycopeptide antibiotics antimicrobial mechanism mechanism of resistance structural modification HIV FIPV, SARS
  • 相关文献

参考文献23

  • 1Parenti F, Cavalleri. Novel glycopeptide antibiotics of the dalbaheptide group [J]. Drugs Future, 1990,15 ( 1 ) :57 - 72.
  • 2Balzarini J, Keyaerts E, Vijgen L, et al. Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics [ J ]. Antiviral Res,2006,72 ( 1 ) : 20 - 33.
  • 3Sinha RR, Yang P, Kodali S, et al. Direct interaction of a vancomycin derivative with bacterial enzymes involved in cell wall biosynthesis[ J]. Chem Biol,2001,8 ( 11 ) : 1 095 - 1 106.
  • 4Marchese A, Balistreri G, Tonoli E, et al. Heterogeneous vancomycin resistance in methicillin resistant Staphylococcus aureus strains isolated in a large Italian hospital [ J ]. Clin Microbiol, 2000,38 ( 2 ) : 866 - 869.
  • 5Hiramatsu K. Vancomycin-resistant Staphylococcus aureus : a new model of antibiotic resistance[J]. Lancet Infect Dis ,2001,1 ( 3 ) : 147 - 155.
  • 6Boyle-Vavra S, Berke SK, Lee JC, et al. Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates[ J ] . Antimicrob Agents Chemother, 2000,44 ( 2 ) : 272 - 277.
  • 7Bambeke FV. Glycopeptides in clinical development:pharmacological profile and clinical perspectives [J]. Curr Opin Pharmacol,2004,4 (5) :471 - 478.
  • 8Wanner J,Tang DT, Casey C, et al. A new and improved method for deglycosidation of glycopeptide antibiotics exemplified with vancomycin, ristocetin, and ramoplanin [ J ]. Bioorg Med Chem Lett,2003,13(6) :1 169 - 1 173.
  • 9Naghibi B, Ghafghazi T, Hajhashemi V, et al. The effect of 2,3- dihydroxybenzolc acid and tempol in prevention of vancomycin- induced nephrotoxicity in rats [ J ]. Toxicology,2007,232 ( 3 ) : 192 - 199.
  • 10Mu YQ, Nodwell M,Pace JL,et al. Vancomyein disulfide derivatives as antibacterial agents [J]. Bioorg Med Chem Lett, 2004,14(3) :735 -738.

同被引文献20

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部